This site is intended for health professionals only

Published on 7 May 2010

Share this story:
Twitter
LinkedIn

Drugs giant “confident around cuts”

teaser

Pharmaceuticals giant GlaxoSmithKline is not worried about looming cuts to government budgets because it is “used to” regular price reductions, its chief executive has told shareholders.

The firm had dealt with a annual 3% reduction in the price put on its products, said Andrew Witty.

“We are moving into unpredictable times. Just in the last week we have seen the government in Greece cut prices by 24% and Germany has cut prices by 10%.”

While the cuts seemed dramatic, GlaxoSmithKline is used to dealing with European price cuts, Mr Witty insisted, and means it remains crucial that “value-for-money” medicine continues to be produced which is “priced at a level for governments to purchase”.

The company board also answered questions about directors’ pay, cheap vaccines for malaria and reducing research in neuroscience. Shareholders passed all resolutions.

Copyright Press Association 2010

GlaxoSmithKline



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn